Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Feb 08, 2017 7:42pm
196 Views
Post# 25819886

RE:RE:TLT could be next!

RE:RE:TLT could be next!
LaserStock29 wrote:
opsd1 wrote: The following article illustrates what we are expecting to happen to the share price of Theralase if the human clinical trials are a success. I've witnessed such gains many times before with these types of stocks and that is why I've invested in TLT:

https://www.stockhouse.com/news/newswire/2017/02/03/the-next-biotech-winner-could-be-replicel

"when a pharma or biotech announces positive news its stock often takes off like a bullet"


Good post!

1. AGM 10:40-12:20 Dr.K

2. Kereport Nov 21 part 2 about 1:30min -3min Dr.J

a. Patients have failed primary treatment
b. All patients to be selected are in the system, therefore the 'pool' we have is defined. 
c. 15-20 Urologists at Toronto Bladder Community centres are aware and eager to send patients
d. FDA have set defined goalposts on 'Patient inclusion criteria' and 'Results'

We're approved and funded and apparently fiddling around 60 days after the AGM on Dec 9

Is there other trials to choose..... Keytruda??   could we be competing for patients??

That's an interesting question.

I think Roger needs to explain this..... like this weekend if we're lucky.   Cause to this investor 60 days with NOTHING is UNACCEPTABLE


Great post indeed. But when could we ever get a chance to see the positive news from human trial results? All we got is only endless waiting, delays after more delays, I am adding all the way from up and down, and I seldom sell for small profit, all the past 3 years, I kept accumulating and persuade my friends, coworkers to accumulate, but what did we get, stupid PP and more delays, when could TLT management ever learn to put small investors ' value at first. Although I feel frustrated, but I still want to average down more to accumulate if I get more money and more chances. Just wish RW could give all the longs some confidence and don't do stupid PP again and again like before. For 3 years as a royal shareholders, we deserve better not worse.
Bullboard Posts